We demonstrate that miR–129-5p inhibits CF-to-MF and CF-to-OF transition via its target genes SOX9 and ASPN, which promote β-catenin, thus identifying the common profibrotic and proosteogenic roles of ASPN and SOX9 in CF. This evidence concerns the gene ASPN and cystic fibrosis.